|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▼
|
|
NIFEDIPINE |
C08CA05 |
DE
|
Currently not available
|
|
DE/H/3595/001/ |
13-03-2014 |
VALID
|
|
NIFLUMIC ACID |
M01AX02 |
DE
|
Not authorised
|
|
|
|
VALID
|
|
NIFLUMIC ACID |
M02AA17 |
DE
|
II
|
|
None |
|
VALID
|
|
NILOTINIB |
L01EA03 |
DE
|
Not authorised
|
13-07-2023 |
|
|
VALID
|
|
NIMESULIDE |
M01AX17 |
DE
|
Not authorised
|
|
|
|
VALID
|
|
NINTEDANIB |
L01EX09 |
DE
|
POM
|
26-02-2020 |
|
|
VALID
|
|
NIRAPARIB |
L01XK02 |
DE
|
POM
|
04-04-2018 |
EMEA/H/C/004249 |
08-01-2018 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
NITRIC OXIDE |
R07AX01 |
DE
|
Currently not available
|
|
DE/H/3773/001/ |
28-04-2014 |
VALID
|
|
NITROGEN |
V03AN04 |
DE
|
Not authorised
|
|
|
|
VALID
|
|
NIVOLUMAB |
L01FF01 |
DE
|
POM
|
|
|
|
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
NIZATIDINE |
A02BA04 |
DE
|
II
|
|
None |
|
VALID
|
|
NOMEGESTROL |
G03DB04 |
DE
|
I
|
|
None |
|
VALID
|
|
NOMEGESTROL AND ESTRADIOL |
G03AA14 |
DE
|
POM
|
|
|
|
VALID
|
|
NORELGESTROMIN AND ETHINYLESTRADIOL |
G03AA13 |
DE
|
I
|
|
None |
|
VALID
|
|
NORETHISTERONE AND ESTROGEN |
G03FA01 |
DE
|
Currently not available
|
|
DE/H/3299/002/ |
11-03-2014 |
VALID
|
|
NORETHISTERONE AND ESTROGEN |
G03FB05 |
DE
|
POM
|
08-02-2024 |
DE/H/0304/001/ |
10-11-2014 |
VALID
|
|
NORFLOXACIN |
J01MA06 |
DE
|
POM
|
12-07-2022 |
DE/H/2420/001/II/001 |
07-05-2009 |
VALID
|
|
NORGESTRIENONE |
G03AC07 |
DE
|
I
|
|
None |
|
VALID
|
|
NORMETHADONE |
R05DA06 |
DE
|
Not authorised
|
|
|
|
VALID
|
|
NOSCAPINE |
R05DA07 |
DE
|
POM
|
30-06-2021 |
|
|
VALID
|
|
NUSINERSEN |
M09AX07 |
DE
|
POM
|
|
EMEA/H/C/004312 |
30-05-2017 |
VALID
|
|
NYSTATIN |
D01AA01 |
DE
|
Not subject to prescription
|
|
None |
|
VALID
|
|
NYSTATIN |
G01AA01 |
DE
|
Not subject to prescription
|
|
None |
|
VALID
|
|
OBIDOXIME |
V03AB13 |
DE
|
Not authorised
|
06-11-2019 |
|
|
VALID
|
|
OBILTOXAXIMAB |
J06BC04 |
DE
|
Not authorised
|
18-01-2021 |
|
|
VALID
|
|
OBINUTUZUMAB |
L01FA03 |
DE
|
POM
|
|
|
|
VALID
|
|
OCTREOTIDE |
H01CB02 |
DE
|
I
|
|
None |
|
VALID
|
|
ODEVIXIBAT |
A05AX05 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004691 |
16-07-2021 |
VALID
|
|
OFATUMUMAB |
L01FA02 |
DE
|
POM
|
|
|
|
VALID
|
|
OFATUMUMAB |
L04AG12 |
DE
|
Not authorised
|
02-06-2021 |
|
|
VALID
|
|
OFLOXACIN |
J01MA01 |
DE
|
POM
|
12-07-2022 |
DE/H/0317/001/II/013 |
16-11-2009 |
VALID
|
|
OLANZAPINE |
N05AH03 |
DE
|
POM
|
22-09-2017 |
DE/H/4037/004/ |
10-11-2014 |
VALID
|
|
OLAPARIB |
L01XK01 |
DE
|
POM
|
03-02-2021 |
|
|
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
OLMESARTAN MEDOXOMIL |
C09CA08 |
DE
|
POM
|
27-02-2020 |
DE/H/0384/003/ |
19-08-2014 |
VALID
|
|
OLMESARTAN MEDOXOMIL AND AMLODIPINE |
C09DB02 |
DE
|
POM
|
|
|
|
VALID
|
|
OLMESARTAN MEDOXOMIL AND DIURETICS |
C09DA08 |
DE
|
POM
|
07-02-2024 |
|
|
VALID
|
|
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE |
C09DX03 |
DE
|
POM
|
|
|
|
VALID
|
|
OLODATEROL |
R03AC19 |
DE
|
I
|
|
None |
|
VALID
|
|
OLOPATADINE |
R01AC08 |
DE
|
Not authorised
|
|
|
|
VALID
|
|
OLOPATADINE |
S01GX09 |
DE
|
POM
|
|
|
|
VALID
|
|
OMBITASVIR, PARITAPREVIR AND RITONAVIR |
J05AP53 |
DE
|
POM
|
|
|
|
VALID
|
|
OMEGA-3-TRIGLYCERIDES INCL. OTHER ESTERS AND ACIDS |
C10AX06 |
DE
|
POM
|
21-08-2018 |
DE/H/3049/001/ |
19-09-2014 |
VALID
|
|
OMOCONAZOLE |
D01AC13 |
DE
|
I + Exemption
|
|
None |
01-01-1998 |
VALID
|
|
OMOCONAZOLE |
G01AF16 |
DE
|
Not authorised
|
|
|
|
VALID
|
|
ONDANSETRON |
A04AA01 |
DE
|
POM
|
21-02-2020 |
DE/H/0641/002/ |
11-08-2014 |
VALID
|
|
OPICAPONE |
N04BX04 |
DE
|
POM
|
|
|
|
VALID
|
